CXCL1 and atherosclerosis: Treatment with DNase I decreased NET formation and ameliorated atherosclerosis in ApoE−/−PAD4 KO mice, reducing levels of IL-1β, TNFα, CCL2, CXCL1, and CXCL2 under both in vitro and in vivo conditions [84].